MSI-H Colorectal Carcinoma — Trials

MSI-H Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

14 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Emory University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–8 of 8 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05714553	NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours	terminated	Phase 1 / Phase 2	19	NuCana plcOTHER	1	Jul 23, 2026	clinicaltrials
NCT06006923	Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer	terminated	Phase 2	1	Anwaar SaeedOTHER	1	Jan 20, 2026	clinicaltrials
NCT03983993